Preclinical development of FL-091, a novel NTSR1 targeting radionuclide drug conjugate for the treatment of NTSR1-positive cancers

被引：0
|
作者：
Zhang, J. [1 ]
Yang, J. [1 ]
Liu, F. [1 ]
Wong, N. C. L. [1 ]
Thrane, K. T. [2 ]
Hallund, M. W. [2 ]
Gronlund, R. V. [2 ]
机构：
[1] Full Life Technol, Shanghai, Peoples R China
[2] Minerva Imaging ApS, Olstykke, Denmark
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-676
引用
收藏
页码：S322 / S323
页数：2
相关论文
共 46 条
  • [11] Development and Characterization of a Novel Peptide-Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors
    Wang, Yayu
    Li, Yadan
    Cao, Jieqiong
    Meng, Qilin
    Li, Xiaocen
    Zhang, Yibo
    Lam, Kit S.
    Hong, An
    Liu, Ruiwu
    Chen, Xiaojia
    BIOMEDICINES, 2021, 9 (08)
  • [12] Preclinical evaluation of FL-031, a novel vector for next generation SSTR2 targeting radioligand therapy for the treatment of SSTR2-positive cancers
    Zhang, J.
    Yang, J.
    Hu, T.
    Xie, Y.
    Liu, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S375 - S375
  • [13] Development of a novel therapeutic CLDN18.2 monoclonal antibody and antibody drug conjugate for the treatment of CLDN18.2 positive cancers
    O'brien, Neil A.
    McDermott, Martina S.
    Zhang, Jun
    Gong, Ke Wei
    Lu, Ming
    Hoffstrom, Benjamin G.
    Conklin, Dylan
    Luo, Tong
    Chau, Kevin
    Liang, Min
    Donahue, Timothy R.
    Glaspy, John A.
    Presta, Leonard
    Slamon, Dennis J.
    CANCER RESEARCH, 2022, 82 (12)
  • [14] Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers
    Kelly, Marcus P.
    Hickey, Carlos
    Makonnen, Sosina
    Coetzee, Sandra
    Jalal, Sumreen
    Wang, Yu
    Delfino, Frank
    Shan, Jing
    Potocky, Terra B.
    Chatterjee, Ishita
    Andreev, Julian
    Kunz, Arthur
    D'Souza, Christopher
    Giurleo, Jason T.
    Nittoli, Thomas
    Trail, Pamela A.
    Thurston, Gavin
    Kirshner, Jessica R.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (07) : 1299 - 1311
  • [15] Development of an antibody-drug conjugate targeting TIM-1 for the treatment of ovarian and renal cell carcinoma
    Thomas, Lawrence J.
    Vitale, Laura
    O'Neill, Thomas
    Dolnick, Ree
    Wallace, Paul K.
    Minderman, Hans
    Gergel, Lauren E.
    Forsberg, Eric M.
    Boyer, James M.
    Storey, James R.
    Hammond, Russell A.
    Widger, Jennifer
    Sundarapandiyan, Karuna
    Crocker, Andrea
    Marsh, Henry C.
    Keler, Tibor
    CANCER RESEARCH, 2014, 74 (19)
  • [16] SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer
    Sussman, Django
    Smith, Leia M.
    Anderson, Martha E.
    Duniho, Steve
    Hunter, Joshua H.
    Kostner, Heather
    Miyamoto, Jamie B.
    Nesterova, Albina
    Westendorf, Lori
    Van Epps, Heather A.
    Whiting, Nancy
    Benjamin, Dennis R.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2991 - 3000
  • [17] Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-Drug Conjugate for Treatment of CLDN18.2-Positive Cancers
    O'Brien, Neil A.
    McDermott, Martina S. J.
    Zhang, Jun
    Gong, Ke Wei
    Lu, Ming
    Hoffstrom, Benjamin
    Luo, Tong
    Ayala, Raul
    Chau, Kevin
    Liang, Min
    Madrid, Athena M.
    Donahue, Timothy R.
    Glaspy, John A.
    Presta, Leonard
    Slamon, Dennis J.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12) : 1365 - 1375
  • [18] Development of a novel antibody-drug conjugate targeting endosialin/TEM-1: potent antitumor activity in sarcoma
    Sala, Gianluca
    Iacobelli, Stefano
    Capone, Emily
    PIccolo, Enza
    Sauniere, Jean-Fred
    Douet, Vanessa Vannucci
    CANCER RESEARCH, 2017, 77
  • [19] Outstanding preclinical efficacy of a novel maytansinoid-antibody-drug conjugate targeting LAMP1 in patient-derived xenograft solid tumors
    Calvet, Loreley
    Lefebvre, Anne-Marie
    Nicolazzi, Celine
    Blot, Lydia
    Thomas, Corinne
    Baudat, Yves
    Cameron, Beatrice
    Garcia-Echeverria, Carlos
    Mayaux, Jean-Francois
    Blanc, Veronique
    Combeau, Cecile
    Naimi, Souad
    Sidhu, Sukhvinder
    CANCER RESEARCH, 2016, 76
  • [20] Preclinical development of YL202, a novel HER3-targeting antibody-drug conjugate (ADC) with novel DNA topoisomerase I inhibitor for treatment of solid tumors
    Xu, Jian
    Zong, Qing
    Zhu, Liang
    Liu, Qigang
    Stann, Sasha
    Cai, Jiaqiang
    CANCER RESEARCH, 2023, 83 (07)
12345